ONCONVTHERAPEUTICS
ONCONVTHERAPEUTICS
Share · US68232V8019 · TRAW (LSSI)
Overview Financial Indicators
1,46 EUR
10,63 % 0,14 EUR
Lang & Schwarz (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 23:59

Current Prices from ONCONVTHERAPEUTICS

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TRAW
USD
06.06.2025 23:59
1,67 USD
1,52 USD
+10,23 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 20,66 % 12,73 % -41,21 % -67,54 % -89,45 % -99,06 %

Company Profile for ONCONVTHERAPEUTICS Share

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa; and has a preclinical program comprising IV/oral rigosertib for COVID-19. It has a license agreement with SymBio Pharmaceuticals Limited; license, development, and commercialization agreement with Pint International SA.; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Company Data

Name ONCONVTHERAPEUTICS
Company Onconova Therapeutics, Inc.
Symbol TRAW
Website https://www.onconova.com
Primary Exchange LSSI Lang & Schwarz
ISIN US68232V8019
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Steven M. Fruchtman M.D.
Market Capitalization 21 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 12 Penns Trail, 18940 Newtown
IPO Date 2013-07-25

Stock Splits

Date Split
23.09.2024 1:25

ID Changes

Date From To
03.04.2024 ONTX TRAW

Ticker Symbols

Name Symbol
Frankfurt 0T2.F
NASDAQ ONTX
NASDAQ TRAW

More Shares

Investors who ONCONVTHERAPEUTICS hold also have the following shares in their portfolio:
EFSF 19/26 MTN
EFSF 19/26 MTN Bond
GraniteShares 3x Long Alphabet Daily ETP
GraniteShares 3x Long Alphabet Daily ETP ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025